Your browser doesn't support javascript.
loading
Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis.
Washino, Satoshi; Shirotake, Suguru; Takeshita, Hideki; Inoue, Masaharu; Miura, Yuji; Hyodo, Yoji; Kagawa, Makoto; Izumi, Keita; Oyama, Masafumi; Kawakami, Satoru; Saito, Kazutaka; Matsuoka, Yoh; Taniuchi, Satsuki; Shintani, Ayumi; Miyagawa, Tomoaki.
Afiliação
  • Washino S; Department of Urology, Jichi Medical University Saitama Medical Center, 1-847, Amanuma-cho, Omiya-ku, Saitama, Saitama, 330-8503, Japan. suwajiisan@yahoo.co.jp.
  • Shirotake S; Musashino Study Group, Saitama, Japan. suwajiisan@yahoo.co.jp.
  • Takeshita H; Department of Uro-Oncology, Saitama Medical University International Medical Center, 1397-1, Yamane, Hidaka, Saitama, 350-1298, Japan.
  • Inoue M; Musashino Study Group, Saitama, Japan.
  • Miura Y; Department of Urology, Saitama Medical Center, Saitama Medical University, 1981, Kamoda, Kawagoe, Saitama, 350-8550, Japan.
  • Hyodo Y; Musashino Study Group, Saitama, Japan.
  • Kagawa M; Department of Urology, Saitama Cancer Center, 818, Ina-machi, Kitaadati-gun, Komuro, Saitama, 362-0806, Japan.
  • Izumi K; Musashino Study Group, Saitama, Japan.
  • Oyama M; Department of Medical Oncology, Toranomon Hospital, 2-2-2, Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
  • Kawakami S; Musashino Study Group, Saitama, Japan.
  • Saito K; Department of Urology, Dokkyo Medical University Saitama Medical Center, 2-1-50, Minami-Koshigaya, Saitama, 343-0845, Japan.
  • Matsuoka Y; Musashino Study Group, Saitama, Japan.
  • Taniuchi S; Department of Urology, Saitama Medical Center, Saitama Medical University, 1981, Kamoda, Kawagoe, Saitama, 350-8550, Japan.
  • Shintani A; Musashino Study Group, Saitama, Japan.
  • Miyagawa T; Department of Urology, Saitama Cancer Center, 818, Ina-machi, Kitaadati-gun, Komuro, Saitama, 362-0806, Japan.
Int J Clin Oncol ; 28(12): 1651-1658, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37658926

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article